|
THAP10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.884800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.563600E-01 |
| Normal-vs-Stage2 |
9.147800E-01 |
| Normal-vs-Stage3 |
2.725600E-01 |
| Normal-vs-Stage4 |
8.611000E-01 |
| Stage1-vs-Stage2 |
5.798600E-01 |
| Stage1-vs-Stage3 |
3.758200E-02 |
| Stage1-vs-Stage4 |
5.152400E-01 |
| Stage2-vs-Stage3 |
3.782000E-01 |
| Stage2-vs-Stage4 |
9.610200E-01 |
| Stage3-vs-Stage4 |
3.619800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.570200E-01 |
| Normal-vs-AfricanAmerican |
3.982400E-01 |
| Normal-vs-Asian |
8.540600E-01 |
| Caucasian-vs-AfricanAmerican |
2.637800E-01 |
| Caucasian-vs-Asian |
9.608200E-01 |
| AfricanAmerican-vs-Asian |
2.981200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.507600E-01 |
| Normal-vs-Female |
8.434600E-01 |
| Male-vs-Female |
3.330800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.026200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.224200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.269800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.178300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.908000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.816020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.354400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.316840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.273900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.496760E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.270600E-01 |
| Classical-VS-Follicular |
4.962100E-02 |
| Classical-VS-Other |
4.935400E-01 |
| Classical-VS-Normal |
5.612800E-01 |
| Tall-VS-Follicular |
2.494800E-01 |
| Tall-VS-Other |
5.817400E-01 |
| Tall-VS-Normal |
6.506400E-01 |
| Follicular-VS-Other |
2.477800E-01 |
| Follicular-VS-Normal |
4.210200E-01 |
| Other-VS-Normal |
4.230800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.019400E-01 |
| Normal-vs-N1 |
6.983600E-01 |
| N0-vs-N1 |
9.516600E-01 |
|
|
